Concepedia

David K. Miyamoto

DK

Statistics

Publications

7

Citations

561

H-Index

7

Active since

2016

Affiliations

University of California, Berkeley(Current)

Harvard University

Memorial Sloan Kettering Cancer Center

Broad Institute

University of Alabama at Birmingham

David K. Miyamoto is an author at University of California, Berkeley specializing in medicine, drug discovery, and molecular docking.

Top concepts

Publications per year

2016–2023

7

Publications

7

GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity

Sharon M. Louie, Lisa A. Crawford, Lucky Ding et al. · Cell chemical biology · 2016 · 151 citations · Full text

, , +8

Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products

Carl C. Ward, Jessica N. Spradlin, Leslie A. Bateman et al. · Cell chemical biology · 2017 · 131 citations · Full text

, , +11

Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target

Allison M. Roberts, David K. Miyamoto, Tucker R. Huffman et al. · ACS Chemical Biology · 2017 · 116 citations

, , +18

Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity

Leslie A. Bateman, Truc Nguyen, Allison M. Roberts et al. · Chemical Communications · 2017 · 80 citations · Full text

, , +18

Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells

Sun‐Mi Park, David K. Miyamoto, Grace Han et al. · Cancer Cell · 2023 · 40 citations · Full text

, , +8

Rows per page

1–5 of 7